Related Experiment Video
Updated: Aug 28, 2025
06:03
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
1.4K
Heterologous prime boost COVID 19 vaccination.
1Université Paris Cité, Assistance publique Hôpitaux de Paris, Hôpital Cochin, Inserm, CIC 1417, I-REIVAC, France.
Infectious Diseases Now
|September 15, 2022
Summary
Heterologous prime boost vaccination, using different vaccine types, enhances immune responses for COVID-19 prevention. This strategy shows usefulness in primary vaccination and booster doses.
Area of Science:
- Immunology
- Vaccinology
- Infectious Disease
Background:
- Heterologous prime boost vaccination involves using distinct vaccines, often from different platforms, for primary immunization or boosters.
- This approach leverages the immunological properties of multiple vaccine types to elicit a comprehensive immune response.
Purpose of the Study:
- To evaluate the efficacy and usefulness of heterologous prime boost vaccination strategies.
- To summarize findings on heterologous prime boost vaccination for COVID-19 prevention.
Main Methods:
- Literature review and analysis of existing articles reporting on heterologous prime boost vaccination outcomes.
- Evaluation of studies focusing on humoral, cellular, and mucosal immune responses induced by this vaccination approach.
Main Results:
- Heterologous prime boost vaccination demonstrates the ability to induce robust humoral and cellular immune responses.
- This vaccination strategy has shown utility in both primary immunization and as booster doses for COVID-19 prevention, particularly when safety concerns arise with other methods.
Conclusions:
- Heterologous prime boost vaccination is a valuable strategy for enhancing immunological protection.
- The combined immunological properties of different vaccine platforms contribute to its demonstrated usefulness in infectious disease prevention, including COVID-19.
